Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Earnanickelon Feb 14, 2017 2:11pm

70 Views

Post# 25844603

RE:RE:Momentum11

This BB has no meaningful effect on the SP, big time players don't have time for chatting about people they think are imposters. Why would someone waste there time posting all the stuff that smartinvesting posts when he/she could just post on every other BB about NF and how "I'll personally pay your losses if you invest in NF" or some bull like that. C'mon bro,think about it.

Bullboard Posts

The Market Online’s Weekly Gold Report – Nov. 27, 2024